Hai Shang

1.3k total citations
53 papers, 1.1k citations indexed

About

Hai Shang is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Hai Shang has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Hai Shang's work include Cyclopropane Reaction Mechanisms (7 papers), Catalytic C–H Functionalization Methods (6 papers) and Natural product bioactivities and synthesis (6 papers). Hai Shang is often cited by papers focused on Cyclopropane Reaction Mechanisms (7 papers), Catalytic C–H Functionalization Methods (6 papers) and Natural product bioactivities and synthesis (6 papers). Hai Shang collaborates with scholars based in China, United Kingdom and United States. Hai Shang's co-authors include Yefeng Tang, Yu Tian, Yuanhao Wang, Juan Feng, Zhong‐Mei Zou, Meng Yu, Zhen Yang, Lingyu Li, Xudong Xu and Zhaofeng Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Scientific Reports and Molecules.

In The Last Decade

Hai Shang

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai Shang China 20 638 357 114 68 65 53 1.1k
Humaira Nadeem Pakistan 19 469 0.7× 263 0.7× 112 1.0× 59 0.9× 20 0.3× 83 986
Ernesto Cano Spain 18 539 0.8× 290 0.8× 147 1.3× 25 0.4× 34 0.5× 38 1.0k
Aarfa Queen India 16 237 0.4× 523 1.5× 136 1.2× 40 0.6× 55 0.8× 21 919
Hang Chu China 8 193 0.3× 261 0.7× 89 0.8× 65 1.0× 31 0.5× 8 472
Maria Manuel Silva Portugal 17 201 0.3× 403 1.1× 83 0.7× 66 1.0× 22 0.3× 36 839
Barbora Orlikova Luxembourg 18 304 0.5× 444 1.2× 244 2.1× 92 1.4× 71 1.1× 23 926
Li‐Qiang Sun United States 16 413 0.6× 320 0.9× 102 0.9× 37 0.5× 27 0.4× 40 873
Norbert Handler Austria 14 243 0.4× 430 1.2× 109 1.0× 28 0.4× 44 0.7× 34 1.0k
Jinhong Feng China 18 239 0.4× 471 1.3× 107 0.9× 56 0.8× 60 0.9× 52 818
Rongcai Yue China 16 116 0.2× 311 0.9× 136 1.2× 97 1.4× 32 0.5× 44 704

Countries citing papers authored by Hai Shang

Since Specialization
Citations

This map shows the geographic impact of Hai Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Shang more than expected).

Fields of papers citing papers by Hai Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Shang. The network helps show where Hai Shang may publish in the future.

Co-authorship network of co-authors of Hai Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Shang. A scholar is included among the top collaborators of Hai Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Shang. Hai Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Jiawei, et al.. (2025). Design, synthesis and evaluation of pterostilbene-indole hybrids as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 128. 130317–130317.
3.
Lv, Xing, Xiaoxue Li, Hai Shang, et al.. (2024). Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance. European Journal of Pharmacology. 983. 176968–176968. 3 indexed citations
4.
Hu, Yue, et al.. (2023). Design, synthesis and evaluation of novel UDCA-aminopyrimidine hybrids as ATX inhibitors for the treatment of hepatic and pulmonary fibrosis. European Journal of Medicinal Chemistry. 264. 116029–116029. 2 indexed citations
5.
6.
Shang, Hai, et al.. (2022). Design, synthesis and anti-inflammatory evaluation of aloe-emodin derivatives as potential modulators of Akt, NF-κB and JNK signaling pathways. European Journal of Medicinal Chemistry. 238. 114511–114511. 23 indexed citations
7.
Sun, Ye, Qiuyu Zhao, Ruiqi Zhang, et al.. (2021). Down-Regulating the Expression of miRNA-21 Inhibits the Glucose Metabolism of A549/DDP Cells and Promotes Cell Death Through the PI3K/AKT/mTOR/HIF-1α Pathway. Frontiers in Oncology. 11. 653596–653596. 18 indexed citations
8.
Li, Wenxin, Zhiqiang Hao, Hai Shang, et al.. (2021). Olaparib effectively treats local recurrence of extrahepatic cholangiocarcinoma in a patient harboring a BRCA2-inactivating mutation: a case report. Annals of Translational Medicine. 9(18). 1487–1487. 8 indexed citations
9.
Li, Lingyu, Hai Shang, Liu Yang, et al.. (2019). Trematosphones A and B, Two Unique Dimeric Structures from the Desert Plant Endophytic Fungus Trematosphaeria terricola. Organic Letters. 21(7). 2139–2142. 22 indexed citations
10.
Jia, Hong‐Mei, Yang Liu, Meng Yu, et al.. (2019). Neuroprotective Effect of Cyperi rhizome against Corticosterone-Induced PC12 Cell Injury via Suppression of Ca2+ Overloading. Metabolites. 9(11). 244–244. 8 indexed citations
11.
Fu, Xi, et al.. (2017). Pathology comparative study on the characteristic CT signs in solid pseudopapillary neoplasm of the pancreas. Experimental and Therapeutic Medicine. 13(6). 3523–3528. 10 indexed citations
12.
Tian, Yu, Yuyang Du, Hai Shang, et al.. (2017). Calenduloside E Analogues Protecting H9c2 Cardiomyocytes Against H2O2-Induced Apoptosis: Design, Synthesis and Biological Evaluation. Frontiers in Pharmacology. 8. 862–862. 25 indexed citations
13.
Jia, Hong‐Mei, Qi Li, Chao Zhou, et al.. (2016). Chronic unpredictive mild stress leads to altered hepatic metabolic profile and gene expression. Scientific Reports. 6(1). 23441–23441. 65 indexed citations
14.
Shang, Hai, Yuanhao Wang, Yu Tian, Juan Feng, & Yefeng Tang. (2014). The Divergent Synthesis of Nitrogen Heterocycles by Rhodium(II)‐Catalyzed Cycloadditions of 1‐Sulfonyl 1,2,3‐Triazoles with 1,3‐Dienes. Angewandte Chemie International Edition. 53(22). 5662–5666. 182 indexed citations
15.
Shang, Hai, Junhua Liu, Ruiyang Bao, et al.. (2014). Biomimetic Synthesis: Discovery of Xanthanolide Dimers. Angewandte Chemie International Edition. 53(52). 14494–14498. 46 indexed citations
16.
Cao, Bo, Hai Shang, Cong Niu, et al.. (2014). Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents. European Journal of Medicinal Chemistry. 85. 498–507. 28 indexed citations
17.
Fu, Junkai, Hai Shang, Zhaofeng Wang, et al.. (2013). Gold‐Catalyzed Rearrangement of Allylic Oxonium Ylides: Efficient Synthesis of Highly Functionalized Dihydrofuran‐3‐ones. Angewandte Chemie International Edition. 52(15). 4198–4202. 90 indexed citations
18.
Shang, Hai, et al.. (2011). Synthesis of saracatinib. Zhongguo xin yao zazhi. 20(23). 2363–2366.
19.
Shang, Hai, Hong Chen, Dongmei Zhao, et al.. (2011). Synthesis and Biological Evaluation of 4α/4β‐Imidazolyl Podophyllotoxin Analogues as Antitumor Agents. Archiv der Pharmazie. 345(1). 43–48. 19 indexed citations
20.
Chen, Hong, Bo Cao, Zaixin Yang, et al.. (2009). A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200. European Journal of Pharmacology. 627(1-3). 69–74. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026